CA996548A - .alpha.-SULFOBENZYLPENICILLIN SALT - Google Patents

.alpha.-SULFOBENZYLPENICILLIN SALT

Info

Publication number
CA996548A
CA996548A CA175,329A CA175329A CA996548A CA 996548 A CA996548 A CA 996548A CA 175329 A CA175329 A CA 175329A CA 996548 A CA996548 A CA 996548A
Authority
CA
Canada
Prior art keywords
sulfobenzylpenicillin
alpha
salt
sulfobenzylpenicillin salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA175,329A
Other languages
English (en)
Other versions
CA175329S (en
Inventor
Tsugio Shimamoto
Hiroaki Nomura
Masahiko Fujita
Hiroaki Okada
Hiroshi Fujisawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of CA996548A publication Critical patent/CA996548A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA175,329A 1972-07-01 1973-06-29 .alpha.-SULFOBENZYLPENICILLIN SALT Expired CA996548A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6630172A JPS5512435B2 (ja) 1972-07-01 1972-07-01

Publications (1)

Publication Number Publication Date
CA996548A true CA996548A (en) 1976-09-07

Family

ID=13311838

Family Applications (1)

Application Number Title Priority Date Filing Date
CA175,329A Expired CA996548A (en) 1972-07-01 1973-06-29 .alpha.-SULFOBENZYLPENICILLIN SALT

Country Status (15)

Country Link
US (1) US3925357A (ja)
JP (1) JPS5512435B2 (ja)
AT (1) AT325206B (ja)
AU (1) AU469986B2 (ja)
BE (1) BE801588A (ja)
CA (1) CA996548A (ja)
CH (1) CH573435A5 (ja)
CS (1) CS168036B2 (ja)
DE (1) DE2332840A1 (ja)
FR (1) FR2190414B1 (ja)
GB (1) GB1386566A (ja)
HU (1) HU166029B (ja)
NL (1) NL7308048A (ja)
PL (1) PL92969B1 (ja)
SE (1) SE402916B (ja)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522148U (ja) * 1978-07-29 1980-02-13
SK288003B6 (sk) * 2001-02-24 2012-10-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xanthin derivatives, method for the preparation thereof, pharmaceutical composition containing thereof and their use
US20030171424A1 (en) * 2002-03-07 2003-09-11 Lin Ai J. Intravenous formulation of artelinic acid for treatment of severe and complicated malaria
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) * 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
CN109503584A (zh) 2006-05-04 2019-03-22 勃林格殷格翰国际有限公司 多晶型
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
EP1852108A1 (en) * 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
WO2009024542A2 (en) * 2007-08-17 2009-02-26 Boehringer Ingelheim International Gmbh Purin derivatives for use in the treatment of fab-related diseases
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0917675A2 (pt) * 2008-08-15 2015-12-01 Boehringer Ingelheim Int compostos orgânicos para cura de ferida
MX2011002558A (es) 2008-09-10 2011-04-26 Boehringer Ingelheim Int Terapia de combinacion para el tratamiento de diabetes y estados relacionados.
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
EA022310B1 (ru) 2008-12-23 2015-12-30 Бёрингер Ингельхайм Интернациональ Гмбх Солевые формы органического соединения
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
MX364651B (es) 2009-11-27 2019-05-03 Boehringer Ingelheim Int Gmbh Star Inhibidores de dpp-iv, tales como la linagliptina, y composiciones farmacéuticas o combinaciones que comprenden los mismos, para usarse en el tratamiento de pacientes diabéticos tipificados genéticamente.
EP2566469B1 (en) 2010-05-05 2022-12-21 Boehringer Ingelheim International GmbH Combination therapy
EA201991014A1 (ru) 2010-06-24 2019-09-30 Бёрингер Ингельхайм Интернациональ Гмбх Лечение диабета
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
US8883800B2 (en) 2011-07-15 2014-11-11 Boehringer Ingelheim International Gmbh Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
WO2013171167A1 (en) 2012-05-14 2013-11-21 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
WO2015128453A1 (en) 2014-02-28 2015-09-03 Boehringer Ingelheim International Gmbh Medical use of a dpp-4 inhibitor
WO2017211979A1 (en) 2016-06-10 2017-12-14 Boehringer Ingelheim International Gmbh Combinations of linagliptin and metformin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1026793A (fr) * 1949-08-02 1953-05-04 American Cyanamid Co Procédé de préparation de sels de pénicilline
NL6803062A (ja) * 1967-03-10 1968-09-11
US3557094A (en) * 1968-01-05 1971-01-19 Pfizer & Co C Substituted alkyl esters of alpha-carboxy aryl penicillins
AT290728B (de) * 1968-09-28 1971-05-15 Takeda Chemical Industries Ltd Verfahren zur herstellung neuer penicilline

Also Published As

Publication number Publication date
PL92969B1 (ja) 1977-04-30
SE402916B (sv) 1978-07-24
HU166029B (ja) 1974-12-28
CS168036B2 (ja) 1976-05-28
FR2190414A1 (ja) 1974-02-01
CH573435A5 (ja) 1976-03-15
JPS5512435B2 (ja) 1980-04-02
AU5760073A (en) 1975-01-09
JPS4925121A (ja) 1974-03-06
BE801588A (fr) 1973-12-28
FR2190414B1 (ja) 1976-07-02
GB1386566A (en) 1975-03-12
DE2332840A1 (de) 1974-01-17
US3925357A (en) 1975-12-09
AU469986B2 (en) 1976-02-26
NL7308048A (ja) 1974-01-03
AT325206B (de) 1975-10-10

Similar Documents

Publication Publication Date Title
CA996548A (en) .alpha.-SULFOBENZYLPENICILLIN SALT
AU462348B2 (en) Saf-t-jet
AU467469B2 (en) Trifluoromethylmercaptoacetamindocephalosphorins
AU454372B2 (en) Childsafe actuator-overcap
CA978946A (en) .alpha.-ARYL-4-SUBSTITUTED PIPERIDINOALKANOL DERIVATIVES
AU469305B2 (en) Deipenylyl-alkanoylaminopyridine
CA999293A (en) .alpha.-AMINO-P-HYDROXYPHENYLACETAMIDOCEPHALOSPORINS
CA960666A (en) 1-aminomethyl-2,2-diaryl-cyclo-propanecarboxamides
AU475339B2 (en) S-substituted-2-thiodenosines
AU475748B2 (en) Napnthopyrans
AU470359B2 (en) Sulphamoylphenyl-imidazolidinones
AU466344B2 (en) Cycloalkyllactamimides
CA1013742A (en) Azabenzo-1,5-diazepines
AU471369B2 (en) Diphenylmethoxyethylamines
AU467008B2 (en) d, d-DIARYLIMIDAZOLE-2-METHANOLS
AU468599B2 (en) 15-oxasteroids
AU468236B2 (en) 2-acyl-5-nitrothiazoles
AU467526B2 (en) Pyronorifamycins
AU473297B2 (en) Indolylimidoylheterocyclics
AU472554B2 (en) Isothocyanobenzoxazoles
CA900984A (en) .alpha.-CARBOLINES
CA904318A (en) .alpha.-POLYHYDROXYPHENYL-2-PIPER-IDINEMETHANOLS
CA900985A (en) .alpha.-CARBOLINES
CA907632A (en) .alpha.-HALO-PHENYLACETAMIDES
CA902108A (en) .alpha.-PROPARGYLAMINOPROPIOPHENONE DERIVATIVE